219 related articles for article (PubMed ID: 28638788)
1. Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.
Tchio Mantho CI; Harbuzariu A; Gonzalez-Perez RR
World J Clin Oncol; 2017 Jun; 8(3):178-189. PubMed ID: 28638788
[TBL] [Abstract][Full Text] [Related]
2. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
[TBL] [Abstract][Full Text] [Related]
3. The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer.
Harbuzariu A; Oprea-Ilies GM; Gonzalez-Perez RR
Medicines (Basel); 2018 Jul; 5(3):. PubMed ID: 30004402
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.
Lipsey CC; Harbuzariu A; Daley-Brown D; Gonzalez-Perez RR
World J Methodol; 2016 Mar; 6(1):43-55. PubMed ID: 27019796
[TBL] [Abstract][Full Text] [Related]
5. Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer.
Harbuzariu A; Gonzalez-Perez RR
Oncotarget; 2018 Apr; 9(26):18239-18253. PubMed ID: 29719602
[TBL] [Abstract][Full Text] [Related]
6. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
[TBL] [Abstract][Full Text] [Related]
8. Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma.
Zafar SF; Nagaraju GP; El-Rayes B
Expert Opin Ther Targets; 2012 Jul; 16(7):707-18. PubMed ID: 22621256
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
10. Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance.
Daley-Brown D; Harbuzariu A; Kurian AA; Oprea-Ilies G; Gonzalez-Perez RR
World J Clin Oncol; 2019 Jun; 10(6):222-233. PubMed ID: 31367531
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases function as novel potential therapeutic targets for cancer.
Zhang H; Shang YP; Chen HY; Li J
Hepatol Res; 2017 Feb; 47(2):149-159. PubMed ID: 27457249
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
14. HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.
Klieser E; Urbas R; Swierczynski S; Stättner S; Primavesi F; Jäger T; Mayr C; Kiesslich T; Fazio PD; Helm K; Neureiter D
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223590
[TBL] [Abstract][Full Text] [Related]
15. Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells.
Schäfer C; Göder A; Beyer M; Kiweler N; Mahendrarajah N; Rauch A; Nikolova T; Stojanovic N; Wieczorek M; Reich TR; Tomicic MT; Linnebacher M; Sonnemann J; Dietrich S; Sellmer A; Mahboobi S; Heinzel T; Schneider G; Krämer OH
Cell Signal; 2017 Jan; 29():218-225. PubMed ID: 27838375
[TBL] [Abstract][Full Text] [Related]
16. The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation.
Xu X; Dong Z; Li Y; Yang Y; Yuan Z; Qu X; Kong B
Int J Biochem Cell Biol; 2013 Mar; 45(3):536-45. PubMed ID: 23262295
[TBL] [Abstract][Full Text] [Related]
17. Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment.
Schizas D; Mastoraki A; Naar L; Spartalis E; Tsilimigras DI; Karachaliou GS; Bagias G; Moris D
World J Gastroenterol; 2018 Nov; 24(41):4635-4642. PubMed ID: 30416311
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells.
Lin PC; Hsieh HY; Chu PC; Chen CS
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30004423
[TBL] [Abstract][Full Text] [Related]
19. Role of adipocytokines and its correlation with endocrine pancreatic function in patients with pancreatic cancer.
Gąsiorowska A; Talar-Wojnarowska R; Kaczka A; Borkowska A; Czupryniak L; Małecka-Panas E
Pancreatology; 2013; 13(4):409-14. PubMed ID: 23890140
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.
Shankar S; Srivastava RK
Adv Exp Med Biol; 2008; 615():261-98. PubMed ID: 18437899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
